Journal of dentistry · 2026
Synbiotic-fluoride therapy as a next-generation non-invasive approach for early enamel lesions.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zaeneldin Ahmed, Bijle Mohammed Nadeem, Abdallah Mohamed Mahmoud, Kwok Jonathan Chun Ming, Rajasekar Vidhyashree, Yiu Cynthia Kar Yung
Аннотация
OBJECTIVE: To investigate the remineralization potential of a synbiotic-fluoride (SF) therapy combining l-arginine (Arg), sodium fluoride (NaF), and Lacticaseibacillus rhamnosus GG (LRGG) under a multi-species pH-cycling model.
METHODS: Artificial enamel carious lesions were created on human enamel specimens and subjected to a 72-h pH-cycling protocol incorporating multi-species biofilm (Streptococcus mutans, Streptococcus sanguinis, and Streptococcus gordonii). Eight groups were assessed: control, 0.03%Arg, 0.22%NaF, LRGG, 0.22%NaF+0.03%Arg, 0.03%Arg+LRGG, 0.22%NaF+LRGG, and the SF therapy. Remineralization outcomes were quantified by mineral density (MD) and mineral gain (MG) assessments using micro-CT, SEM-EDX for Ca/P, change in surface nano-hardness (ΔSNH) and nanohardness recovery (SHR), and biochemical enamel calcium/phosphate content analysis.
RESULTS: Post pH-cycling, SF therapy had the highest MD, MG, and % remineralization (p < 0.001). The SF therapy also exhibited the significantly highest Ca/P ratio on SEM-EDX (p < 0.001), along with the highest SNH, ΔSNH, and SHR , indicating superior remineralization than other groups (p < 0.001). Calcium and phosphate content further confirmed the enhanced remineralization potential of SF therapy. While dualagent combinations demonstrated greater remineralization than monotherapies, none matched the synergistic effect observed with the SF therapy.
CONCLUSIONS: The combined application of Arg, F, and LRGG synergistically enhances enamel remineralization under dynamic biofilm-mediated conditions, outperforming both individual/combined treatment components.
CLINICAL SIGNIFICANCE: Synbiotic-fluoride therapy represents a biofilm-mediated, noninvasive strategy for managing early enamel carious lesions, offering substantial advantages over fluoride alone. The therapy is aimed at high caries-risk individuals for primary and secondary caries prevention by promoting a biotic approach that ultimately aims to establish an eubiotic state.
METHODS: Artificial enamel carious lesions were created on human enamel specimens and subjected to a 72-h pH-cycling protocol incorporating multi-species biofilm (Streptococcus mutans, Streptococcus sanguinis, and Streptococcus gordonii). Eight groups were assessed: control, 0.03%Arg, 0.22%NaF, LRGG, 0.22%NaF+0.03%Arg, 0.03%Arg+LRGG, 0.22%NaF+LRGG, and the SF therapy. Remineralization outcomes were quantified by mineral density (MD) and mineral gain (MG) assessments using micro-CT, SEM-EDX for Ca/P, change in surface nano-hardness (ΔSNH) and nanohardness recovery (SHR), and biochemical enamel calcium/phosphate content analysis.
RESULTS: Post pH-cycling, SF therapy had the highest MD, MG, and % remineralization (p < 0.001). The SF therapy also exhibited the significantly highest Ca/P ratio on SEM-EDX (p < 0.001), along with the highest SNH, ΔSNH, and SHR , indicating superior remineralization than other groups (p < 0.001). Calcium and phosphate content further confirmed the enhanced remineralization potential of SF therapy. While dualagent combinations demonstrated greater remineralization than monotherapies, none matched the synergistic effect observed with the SF therapy.
CONCLUSIONS: The combined application of Arg, F, and LRGG synergistically enhances enamel remineralization under dynamic biofilm-mediated conditions, outperforming both individual/combined treatment components.
CLINICAL SIGNIFICANCE: Synbiotic-fluoride therapy represents a biofilm-mediated, noninvasive strategy for managing early enamel carious lesions, offering substantial advantages over fluoride alone. The therapy is aimed at high caries-risk individuals for primary and secondary caries prevention by promoting a biotic approach that ultimately aims to establish an eubiotic state.